ArticleScientific reports2017

TCR-like antibodies mediate complement and antibody-dependent cellular cytotoxicity against Epstein-Barr virus-transformed B lymphoblastoid cells expressing different HLA-A*02 microvariants.

Junyun Lai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.